The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity

European Journal of Pharmacology

Volumn 482, Issue 1-3, 2003, Pages 151-154

  Johnson Davis, Kamisha L ^a   Fleckenstein, Annette E ^a   Wilkins, Diana G ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

5 HT (5 hydroxytrytamine, serotonin); Dopamine; Hyperthermia; Neurotoxicity; Pharmacokinetics

Indexed keywords

DOPAMINE; METHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOSE CALCULATION; DRUG BRAIN LEVEL; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERANCE; FRONTAL CORTEX; HIPPOCAMPUS; HYPERTHERMIA; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

EID: 0344305493     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.09.063     Document Type: Article

References (12)

1. Albers D.S., Sonsalla P.K. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275:1995;1104-1114.
2. Ali S.F., Newport G.D., Slikker W. Jr. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents. Ann. N.Y. Acad. Sci. 801:1996;187-198.
3. Bowyer J.F., Tank A.W., Newport G.D., Slikker W. Jr., Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260:1992;817-824.
4. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W. Jr., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268:1994;1571-1580.
5. Chapin D.S., Lookingland K.J., Moore K.E. Effects of LC mobile phase composition retention times for biogenic amines and their precursors and metabolite. Curr. Sep. 7:1986;68-70.
6. Gibb J.W., Hanson G.R., Johnson M. Neurochemical mechanisms of toxicity. Cho A.K., Segal D.S. Amphetamine and its Analogs. 1994;269-295 Academic Press, San Diego, CA.
7. Gygi M.P., Gygi S.P., Johnson M., Wilkins D.G., Gibb J.W., Hanson G.R. Mechanisms for tolerance to methamphetamine effects. Neuropharmacology. 35:1996;751-757.
8. Kokoshka J.M., Fleckenstein A.E., Wilkins D.G., Hanson G.R. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J. Neurochem. 75:2000;2095-2102.
9. Lowry O.H., Rosebrough N., Farr A., Randall R. Protein measurements with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
10. Riddle E.L., Kokoshka J.M., Wilkins D.G., Hanson G.R., Fleckenstein A.E. Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur. J. Pharmacol. 435:2002;181-185.
11. Schmidt C.J., Sonsalla P.K., Hanson G.R., Peat M.A., Gibb J.W. Methamphetamine-induced depression of monoamine synthesis in the rats: development of tolerance. J. Neurochem. 44:1985;852-855.
12. Stephans S., Yamamoto B. Methamphetamine pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience. 72:1996;593-600.